Suppr超能文献

慢性髓性白血病异基因骨髓移植后骨髓的组织病理学

Histopathology of bone marrow after allogeneic bone marrow transplantation for chronic myeloid leukaemia.

作者信息

Rousselet M C, Kerjean A, Guyétant S, François S, Saint-André J P, Ifrah N

机构信息

Laboratoire d'Anatomie Pathologique, Centre Hospitalier Universitaire, Angers, France.

出版信息

Pathol Res Pract. 1996 Aug;192(8):790-5. doi: 10.1016/s0344-0338(96)80052-5.

Abstract

The histopathology of bone marrow after allogeneic bone marrow transplantation for chronic myeloid leukaemia (CML) was studied in 20 bone marrow biopsy specimens from 14 patients. Biopsies were performed at day 30 post-transplantion (5 biopsies), between day 90 and day 100 (14 biopsies), and one year post-transplantation (1 biopsy). Eight biopsies taken at day 30 post-transplantation for lymphoproliferative disorder were studied as controls. Granulopoiesis was predominant in all day 30 bone marrows in patients treated for CML. In 2 cases, rejection was suspected because of marrow hypoplasia at day 30: one case developed acute leukaemia soon after persistant hypoplasia at day 90 while the evolution of the other case was good. Two day 30 biopsies showed granulocytic hyperplasia but follow-up proved complete remission of CML. Thus, in our series, early biopsies at day 30 did not have any prognostic value. Twelve cases at day 90-100 showed little modifications, such as minor dyserythropoiesis and dysmegakaryopoiesis. One case showed granulocytic hyperplasia at day 100 but bone marrow was normal one year later and the patient in complete remission. The haematopoietic reconstitution after allogeneic bone marrow transplantation may present a transient granulocytic hyperplasia that must not be diagnosed as a persistence of CML.

摘要

对14例慢性粒细胞白血病(CML)患者进行异基因骨髓移植后骨髓的组织病理学进行了研究,共分析了20份骨髓活检标本。活检分别在移植后30天(5份活检标本)、90至100天(14份活检标本)以及移植后1年(1份活检标本)进行。另外选取8份移植后30天因淋巴增殖性疾病进行的活检标本作为对照。接受CML治疗的患者在移植后30天的所有骨髓中,粒细胞生成均占主导。2例患者因移植后30天骨髓发育不全而怀疑有排斥反应:1例在90天持续发育不全后不久发展为急性白血病,而另1例病情进展良好。2份移植后30天的活检标本显示粒细胞增生,但随访证明CML完全缓解。因此,在我们的系列研究中,移植后30天的早期活检没有任何预后价值。90至100天的12例患者显示变化不大,如轻度的红细胞生成异常和巨核细胞生成异常。1例患者在100天时显示粒细胞增生,但1年后骨髓正常,患者处于完全缓解状态。异基因骨髓移植后的造血重建可能会出现短暂的粒细胞增生,不应将其诊断为CML持续存在。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验